FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387054429> ?p ?o ?g. }

• W4387054429 endingPage "625" @default.
• W4387054429 startingPage "625" @default.
• W4387054429 abstract "BACKGROUND: Lower abdominal pain during menses, affects up to 91% of individuals who menstruate. The most common method of menstrual pain relief is non-steroidal anti-inflammatory drugs (NSAIDS). However, evidence suggests transcutaneous electrical nerve stimulation (TENS) may provide an alternative to such pharmacological interventions. PURPOSE: This was a feasibility study that is part of an ongoing investigation into the efficacy of an entirely remote study using a wireless and app based commercial TENS for menstrual pain relief. METHODS: Eight menstruating individuals (25 ± 4.24 years old, 22.13 ± 2.76 BMI) completed three consecutive menstrual cycles using the Therabody Power Dot TENS unit in randomized order: single-unit (Uno), dual-unit (Duo), NSAID (control). The Uno cycle used a single Power Dot pod connected to 2 electrode pads through a set of lead cables. The Duo cycle utilized two Power Dot pods connected to 4 electrode pads through a set of two lead cables. Whoop was used to collect physiologic quantitative and qualitative data during each menstrual cycle. During the Uno and Duo cycles, participants were instructed to place Power Dot on their abdomen over the area of pain and to increase the device stimulation to a comfortable intensity. Scores were collected through the Power Dot application. During all cycles, including control, participants were instructed to record NSAID use along with pre-and post-pain scores. Compliance was assessed based on completion of a daily Whoop survey, reporting pre/post pain scores each cycle, and completing all treatments. RESULTS: Seven (7/8) participants completed all three months of treatment. All eight (8/8) participants successfully answered the Whoop survey each day of participation in the study. Lastly, all participants (8/8) reported pre/post pain scores in the Power Dot app upon use, and reported NSAID use in the Whoop app. CONCLUSION: To our knowledge, this is the first study that was conducted on dysmenorrhea and TENS outside of a lab setting. Collection of data through a mobile application is not only more representative of how participants would use the device outside of the laboratory setting, but it also would mitigate error that is introduced from retrospective recall." @default.
• W4387054429 created "2023-09-27" @default.
• W4387054429 creator A5004213596 @default.
• W4387054429 creator A5007148681 @default.
• W4387054429 creator A5009197171 @default.
• W4387054429 creator A5022938608 @default.
• W4387054429 creator A5052549518 @default.
• W4387054429 creator A5090273300 @default.
• W4387054429 date "2023-09-01" @default.
• W4387054429 modified "2023-10-12" @default.
• W4387054429 title "The Role Of Transcutaneous Electrical Nerve Stimulation (TENS) For Menstrual Pain Relief: A Feasibility Study" @default.
• W4387054429 doi "https://doi.org/10.1249/01.mss.0000985656.49458.d6" @default.
• W4387054429 hasPublicationYear "2023" @default.
• W4387054429 type Work @default.
• W4387054429 citedByCount "0" @default.
• W4387054429 crossrefType "journal-article" @default.
• W4387054429 hasAuthorship W4387054429A5004213596 @default.
• W4387054429 hasAuthorship W4387054429A5007148681 @default.
• W4387054429 hasAuthorship W4387054429A5009197171 @default.
• W4387054429 hasAuthorship W4387054429A5022938608 @default.
• W4387054429 hasAuthorship W4387054429A5052549518 @default.
• W4387054429 hasAuthorship W4387054429A5090273300 @default.
• W4387054429 hasBestOaLocation W43870544291 @default.
• W4387054429 hasConcept C126322002 @default.
• W4387054429 hasConcept C141071460 @default.
• W4387054429 hasConcept C142724271 @default.
• W4387054429 hasConcept C168563851 @default.
• W4387054429 hasConcept C1862650 @default.
• W4387054429 hasConcept C204787440 @default.
• W4387054429 hasConcept C24998067 @default.
• W4387054429 hasConcept C2779058012 @default.
• W4387054429 hasConcept C2779983558 @default.
• W4387054429 hasConcept C2780118021 @default.
• W4387054429 hasConcept C42219234 @default.
• W4387054429 hasConcept C71315377 @default.
• W4387054429 hasConcept C71924100 @default.
• W4387054429 hasConceptScore W4387054429C126322002 @default.
• W4387054429 hasConceptScore W4387054429C141071460 @default.
• W4387054429 hasConceptScore W4387054429C142724271 @default.
• W4387054429 hasConceptScore W4387054429C168563851 @default.
• W4387054429 hasConceptScore W4387054429C1862650 @default.
• W4387054429 hasConceptScore W4387054429C204787440 @default.
• W4387054429 hasConceptScore W4387054429C24998067 @default.
• W4387054429 hasConceptScore W4387054429C2779058012 @default.
• W4387054429 hasConceptScore W4387054429C2779983558 @default.
• W4387054429 hasConceptScore W4387054429C2780118021 @default.
• W4387054429 hasConceptScore W4387054429C42219234 @default.
• W4387054429 hasConceptScore W4387054429C71315377 @default.
• W4387054429 hasConceptScore W4387054429C71924100 @default.
• W4387054429 hasIssue "9S" @default.
• W4387054429 hasLocation W43870544291 @default.
• W4387054429 hasOpenAccess W4387054429 @default.
• W4387054429 hasPrimaryLocation W43870544291 @default.
• W4387054429 hasRelatedWork W1483064925 @default.
• W4387054429 hasRelatedWork W2001420351 @default.
• W4387054429 hasRelatedWork W2061838089 @default.
• W4387054429 hasRelatedWork W2109392253 @default.
• W4387054429 hasRelatedWork W2113347213 @default.
• W4387054429 hasRelatedWork W2165590061 @default.
• W4387054429 hasRelatedWork W3159250744 @default.
• W4387054429 hasRelatedWork W4256514411 @default.
• W4387054429 hasRelatedWork W4292236216 @default.
• W4387054429 hasRelatedWork W2083697902 @default.
• W4387054429 hasVolume "55" @default.
• W4387054429 isParatext "false" @default.
• W4387054429 isRetracted "false" @default.
• W4387054429 workType "article" @default.